ABOUT US
VINCENT CHENEY
Founder and partner, Nextep
We have the ability to foster effective collaborations between specialized consultancies across Europe
- A European wide consultancy group founded by 4 locally grounded firms
- One multifunctional and integrated team
- We address the market access and public affairs needs of pharmaceutical, biotech and medical devices companies across European markets
- Our registered status allows our clients to contract with MEDVANCE as a legal entity
What do we offer ?
- Strategic market access and pricing advice
- Local HTA submission and negotiation support
- Combined market access and public affairs strategies
- Strategic deployment support and advice in European healthcare markets
5
Locations
In the main healthcare markets
80
PEOPLE
Across Europe
+300
PROJECTS AND INITIATIVES IN 2017
Across various HEALTHCARE SECTORS
NEWS
An analysis of what to expect from the upcoming review of the EU pharmaceutical legislation
Health policy experts are currently racing against time to finalise their contributions to one of the most important EU health care reforms in decades, the revision of the general pharmaceutical legislation
Italian home care on the verge of digital transformation
The Covid-19 pandemic hit the Italian economy harder than other European countries. The country was hit first and the hardest by the health crisis.
The EU ready to play the health cooperation card, but who holds the cards?
On 15 September, European Commission President Ursula Von Der Leyen gave her annual State of the Union address to the European Parliament.
PUBLICATIONS
Posters and other publications
Medvance’s expertise in European and country specific Market Access is represented in our participation in international conferences. During those conferences, such as ISPOR Europe or BIO International convention, experts from our teams analyze and summarize the European trends for Market access in posters. This section regroups all the posters accepted and presented during those conferences.
